Fred Alger Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-91,807
| Closed | -$1.87M | – | 432 |
|
|
2024
Q4 | $1.87M | Sell |
91,807
-29,509
| -24% | -$601K | 0.01% | 335 |
|
|
2024
Q3 | $3.53M | Buy |
121,316
+94,302
| +349% | +$2.75M | 0.02% | 280 |
|
|
2024
Q2 | $627K | Buy |
+27,014
| New | +$627K | ﹤0.01% | 368 |
|
|
2022
Q3 | – | Sell |
-8,983
| Closed | -$264K | – | 527 |
|
|
2022
Q2 | $264K | Buy |
+8,983
| New | +$264K | ﹤0.01% | 421 |
|
|
2021
Q2 | – | Sell |
-16,634
| Closed | -$950K | – | 517 |
|
|
2021
Q1 | $950K | Sell |
16,634
-244
| -1% | -$13.9K | ﹤0.01% | 390 |
|
|
2020
Q4 | $1.41M | Buy |
+16,878
| New | +$1.41M | ﹤0.01% | 348 |
|